4/A
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001209191-19-021971
Chief Tech. Operations Officer sold 500 shares at $38.44 ($19,220)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Newell Joe Chief Tech. Operations Officer | 2019-02-01 | Sale | −500 | $38.44 | $19,220 | 31,858 | D: show line 1 in the form |
| Open-market sales · 500 sh · avg $38.44 · $19,220 | |||||||
Loading xslF345X03/doc4a.xml…